Crea AI
Scientific support for reproductive diagnostics and laboratory workflows
Crea AI
Scientific support for reproductive diagnostics and laboratory workflows
Scientific support for reproductive diagnostics and laboratory workflows
Scientific support for reproductive diagnostics and laboratory workflows

Andro Crea is a reproductive laboratory technology initiative developed in association with the clinical and laboratory experience ecosystem of Crea Conceptions.
Built from long-standing exposure to assisted reproduction workflows, Andro Crea was created with a focused objective — to support greater consistency, structure and operational confidence across reproductive laboratory environments through thoughtfully designed digital systems.
Over time, increasing laboratory volumes, workflow variability and the growing importance of reproducibility in fertility diagnostics have highlighted the need for more structured digital assistance within routine laboratory practice. Andro Crea was established to contribute to this evolving need through workflow-oriented technology designed to work alongside laboratory teams and existing clinical processes.
Its first platform initiative, Crea AI, is being developed as an assistive AI-powered laboratory workflow platform beginning with semen analysis applications.
Rather than replacing laboratory expertise, Crea AI is designed to support embryologists, andrology teams and laboratory professionals through structured digital assistance intended to improve workflow consistency, review confidence and operational standardisation.
The platform is being built around a philosophy that technology should strengthen laboratory practice while keeping scientific interpretation and clinical responsibility within the laboratory environment. Launching initially within reproductive diagnostics, Andro Crea is being developed with a broader long-term vision for digitally assisted laboratory workflows across the assisted reproduction ecosystem.
Many fertility assessment workflows continue to rely significantly on manual interpretation, which can contribute to inter-operator variability, limited reproducibility and uneven reporting practices across laboratory settings.
Because early diagnostic observations may influence clinical decision-making and treatment pathways, greater structure and standardization in reproductive diagnostics are becoming increasingly important.
Crea AI is being developed by Andro Crea as a modular scientific platform intended to support greater structure, consistency and usability in reproductive laboratory workflows, beginning with semen analysis.

Supporting laboratory teams with structured digital assistance designed for consistency, review confidence and workflow reliability
Crea AI is designed to integrate computer vision with clinical workflow design in support of more standardised fertility assessment across laboratory settings.
Launching with semen analysis as its initial application, the platform is designed with a broader vision for reproductive laboratory workflows across the assisted reproduction value chain.
Current platform focus

Crea AI is being developed to support greater consistency, workflow structure and practical usability across reproductive laboratory settings.
Supports standardization
Designed to support more consistent laboratory workflows through structured digital analysis.
Works within existing laboratory processes
Built for integration into routine operating environments with minimal disruption to established workflows.
Structured outputs for review
Organised analysis outputs are intended to support laboratory review and interpretation processes.
Modular platform foundation
Designed as a platform architecture that can support broader reproductive diagnostics applications over time.

Crea AI is currently opening access to a limited number of laboratories and institutional users as part of its early platform deployment and evaluation journey. This access is intended for authorised settings seeking to explore structured digital support for semen analysis workflows while contributing to informed implementation and platform refinement.
What participating laboratories receive
Crea AI is being developed by Andro Crea Innovations with inputs shaped by extensive real-world experience in assisted reproduction laboratory practice.
The platform’s development is informed by decades of exposure to embryology, andrology and IVF laboratory workflows, including global familiarity with fertility practice environments across India, the Middle East, the UK and the US.
This grounding in practical laboratory science is combined with AI and workflow design efforts intended to build more structured digital support for reproductive diagnostics, beginning with semen analysis.

Participating laboratories gain early access to a developing reproductive diagnostics platform designed to support greater workflow structure, consistency and practical usability across laboratory settings.
Current use context
Access is currently limited to authorised institutions and laboratories participating in controlled early-access settings.

Crea AI is being developed as a modular reproductive diagnostics platform, beginning with structured support for semen analysis workflows such as count, motility and morphology.
No. Crea AI is intended to support laboratory workflows and review processes, not replace scientific oversight, laboratory judgment or clinical decision-making.
Crea AI is being designed for use within existing microscope image and video-based laboratory processes, with the aim of minimizing disruption to established workflows.
Access is currently limited to authorized institutions and laboratories participating in controlled early-access, evaluation or implementation settings.
The platform is currently being introduced through structured early institutional access, with onboarding support and feedback-led implementation.
Institutions may request access through the contact pathway provided on the site. Eligible users will be guided through the next steps for onboarding and participation.
Crea AI is currently being introduced through controlled early-access settings as the platform continues to evolve through structured implementation and evaluation.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.